Increases in controlled ‐release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population‐based study

ConclusionsAfter its subsidy, the uptake of low ‐dose oxycodone/naloxone CR was greater than expected if it were substituting the single‐ingredient oxycodone CR, resulting in an expansion of the oxycodone CR market.

Source: Pharmacoepidemiology and Drug Safety - November 13, 2018 Category: Drugs & Pharmacology Authors: Andrea L. Schaffer, Emily A. Karanges, Nicholas A. Buckley, Andrew Wilson, Louisa Degenhardt, Briony Larance, Sallie ‐Anne Pearson Tags: ORIGINAL REPORT Source Type: research